2-26184779-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001168241.2(GAREM2):c.931G>A(p.Ala311Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000253 in 1,500,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001168241.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GAREM2 | NM_001168241.2 | c.931G>A | p.Ala311Thr | missense_variant | 4/6 | ENST00000401533.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GAREM2 | ENST00000401533.7 | c.931G>A | p.Ala311Thr | missense_variant | 4/6 | 1 | NM_001168241.2 | P1 | |
GAREM2 | ENST00000407684.1 | c.700G>A | p.Ala234Thr | missense_variant | 3/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151928Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000208 AC: 2AN: 96324Hom.: 0 AF XY: 0.0000371 AC XY: 2AN XY: 53876
GnomAD4 exome AF: 0.0000267 AC: 36AN: 1348116Hom.: 0 Cov.: 30 AF XY: 0.0000196 AC XY: 13AN XY: 663930
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151928Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74212
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.931G>A (p.A311T) alteration is located in exon 4 (coding exon 4) of the GAREM2 gene. This alteration results from a G to A substitution at nucleotide position 931, causing the alanine (A) at amino acid position 311 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at